InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by TOMSICEK MICHAEL JOHN. Officer active across 1 companies, notably CRISPR Therapeutics AG. Aggregated, 2 disclosures have been published. The latest transaction was disclosed on 6 August 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€374,92425,000 shares@ €14.997100.0% of flow
Common Shares
SEC:0001209191-21-050719·
€374,92425,000 shares@ €14.9970.0080% mcap50.0% of flow
Common Shares
SEC:0001209191-21-050719:0·
2 of 2 declarations
